Details for Patent: 6,426,335

✉ Email this page to a colleague

Summary for Patent: 6,426,335

Title:	Vascular endothelial growth factor (VEGF) nucleic acid ligand complexes
Abstract:	This invention discloses a method for preparing a complex comprised of a VEGF Nucleic Acid Ligand and a Non-Immunogenic, High Molecular Weight Compound or Lipophilic Compound by identifying a VEGF Nucleic Acid Ligand by SELEX methodology and associating the VEGF Nucleic Acid Ligand with a Non-Immunogenic, High Molecular Weight Compound or Lipophilic Compound. The invention further discloses Complexes comprising one or more VEGF Nucleic Acid Ligands in association with a Non-Immunogenic, High Molecular Weight Compound or Lipophilic Compound. The invention further includes a Lipid construct comprising a VEGF Nucleic Acid Ligand or Complex and methods for making the same.
Inventor(s):	Janjic; Nebojsa (Boulder, CO), Gold; Larry (Boulder, CO), Schmidt; Paul (Niwot, CO), Vargeese; Chandra (Thornton, CO), Willis; Michael (Louisville, CO)
Assignee:	Gilead Sciences, Inc. (Foster City, CA)
Application Number:	09/254,968
Patent Claim Types: see list of patent claims	Use;

Drugs Protected by US Patent 6,426,335

Glossary

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Patented / Exclusive Use	>Submissiondate

Foreign Priority and PCT Information for Patent: 6,426,335

PCT Information
PCT Filed	October 17, 1997	PCT Application Number:	PCT/US97/18944
PCT Publication Date:	May 07, 1998	PCT Publication Number:	WO98/18480

International Family Members for US Patent 6,426,335

Subscribe to access the full database, or Sign Up
Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
European Patent Office	0957929	⤷ Sign Up	91252	Luxembourg	⤷ Sign Up
European Patent Office	0957929	⤷ Sign Up	300234	Netherlands	⤷ Sign Up
European Patent Office	0957929	⤷ Sign Up	PA2006004	Lithuania	⤷ Sign Up
European Patent Office	0957929	⤷ Sign Up	CA 2006 00021	Denmark	⤷ Sign Up
European Patent Office	0957929	⤷ Sign Up	SPC024/2006	Ireland	⤷ Sign Up
European Patent Office	0957929	⤷ Sign Up	PA2006004,C0957929	Lithuania	⤷ Sign Up
>Country	>Patent Number	>Estimated Expiration	>Supplementary Protection Certificate	>SPC Country	>SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.